The combination of angiotensin receptor-neprilysin inhibitor and sodium-glucose cotransporter-2 inhibitors in heart failure with reduced ejection fraction patients comorbid with diabetes mellitus
Event:
ESC Congress 2020
Topic:
Pharmacotherapy
Session:
Chronic Heart Failure ePosters
